Biotechnology At its April meeting, the European Medicines Pharmacovigilance Risk Assessment Committee (PRAC), started new reviews of COVID-19 vaccines, as well as concluding that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca), as reported earlier this week. 9 April 2021